Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Lipocine Inc. LPCN
$4.28
-$0.5 (-11.66%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
25694685.00000000
-
week52high
0.96
-
week52low
0.23
-
Revenue
500000
-
P/E TTM
-2
-
Beta
0.93875400
-
EPS
-0.12000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 12:30
Описание компании
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis; LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the management of decompensated cirrhosis; LPCN 1154, an investigational new drug application to conduct a Phase 2 study in Postpartum depression; LPCN 2101 for women with epilepsy, which has completed pre-clinical study; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 26 авг 2021 г. |
| Cantor Fitzgerald | Overweight | 24 июн 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 27 мая 2021 г. |
| Ladenburg Thalmann | Buy | Neutral | 10 дек 2020 г. |
| HC Wainwright & Co. | Buy | Buy | 27 мая 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Patel Mahesh V. | A | 2542395 | 300000 | 03 янв 2023 г. |
| Fogarty Krista | A | 229850 | 91850 | 22 дек 2022 г. |
| Patel Mahesh V. | A | 2242395 | 112500 | 22 дек 2022 г. |
| Papapetropoulos Spyros | A | 21739 | 21739 | 22 ноя 2022 г. |
| Patel Mahesh V. | A | 1478090 | 75000 | 14 ноя 2022 г. |
| Nomikos George | A | 125000 | 125000 | 01 ноя 2022 г. |
| Patel Mahesh V. | A | 1403090 | 100000 | 27 сент 2022 г. |
| Higuchi John W. | A | 307490 | 22000 | 08 июн 2022 г. |
| Ono Richard Dana | A | 136000 | 22000 | 08 июн 2022 г. |
| Jene Jill M. | A | 32000 | 22000 | 08 июн 2022 г. |
Новостная лента
Lipocine to Present at Biotech Showcase
PRNewsWire
05 янв 2023 г. в 08:00
Company Management Will Also Host Meetings at LifeSci Partners Corporate Access Event SALT LAKE CITY , Jan. 5, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System ("CNS") disorders by leveraging its proprietary platform to develop differentiated products, today announced that its management will present at the Biotech Showcase and host institutional investor and partnering meetings at this event and a Corporate Access Event organized by LifeSci Partners. Both in-person events will take place January 9-11, 2023, in San Francisco, California.
Lipocine to Present at Ladenburg Thalmann 2022 Healthcare Conference
PRNewsWire
22 сент 2022 г. в 16:10
SALT LAKE CITY , Sept. 22, 2022 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on leveraging its proprietary Lip'ral platform to augment therapeutics through effective oral delivery by developing differentiated products relative to standard of care, announced today that it will present at the Ladenburg Thalmann 2022 Healthcare Conference on September 29 in New York.
7 Undervalued Penny Stocks With Major Upside
InvestorPlace
29 мар 2022 г. в 19:34
Each of these penny stocks has proven momentum throughout 2022 and major upside on top of the returns through the the first quarter. The post 7 Undervalued Penny Stocks With Major Upside appeared first on InvestorPlace.